International Biotechnology Trust’s United Therapeutics UTHR Stock Holding History

International Biotechnology Trust’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$7.66M	Sell	33,959 -18,800	-36%	-$4.33M	2.58%	14
2023 Q2	$11.6M	Buy	52,759 +24,259	+85%	+$5.37M	3.55%	9
2023 Q1	$6.38M	Buy	28,500 +13,500	+90%	+$3.33M	1.78%	18
2022 Q4	$4.17M	Hold	15,000	–	–	1.29%	26
2022 Q3	$3.14M	Buy	15,000 +10,287	+218%	+$2.3M	1.01%	30
2022 Q2	$20K	Sell	4,713 -15,287	-76%	-$3.11M	0.21%	65
2022 Q1	$2.94M	Buy	+20,000	New	+$3.81M	0.66%	36
2021 Q3	–	Sell	-43,300	Closed	-$7.77M	–	75
2021 Q2	$7.77M	Buy	43,300 +16,700	+63%	+$3.18M	2.05%	15
2021 Q1	$4.45M	Buy	+26,600	New	+$4.44M	1.18%	23

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

International Biotechnology Trust's UTHR Position: Q3 2023 in Review

International Biotechnology Trust reduced its United Therapeutics (UTHR) stake by 36% in Q3 2023, selling an estimated $4.33M and leaving 33,959 shares worth $7.66M. The position accounts for 2.58% of the portfolio, ranked #14.

International Biotechnology Trust first reported a position in UTHR in Q1 2021 and has held it in 9 quarters since. The position peaked at $11.6M in Q2 2023. 508 funds tracked by Wall St. Rank hold UTHR as of Q3 2023.

International Biotechnology Trust held 33,959 shares of United Therapeutics worth $7.66M as of Q3 2023.
International Biotechnology Trust sold 18,800 United Therapeutics shares in Q3 2023, an estimated $4.33M.
United Therapeutics made up 2.58% of International Biotechnology Trust's portfolio in Q3 2023, its #14 holding.
International Biotechnology Trust first reported a position in United Therapeutics in Q1 2021 and has held it in 9 quarters since.
International Biotechnology Trust's United Therapeutics position peaked at $11.6M in Q2 2023.
508 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.